349 related articles for article (PubMed ID: 35434900)
1. Current gaps in management and timely referral of cardiorenal complications among people with type 2 diabetes mellitus in the Middle East and African countries: Expert recommendations.
Sonmez A; Sabbour H; Echtay A; Rahmah AM; Alhozali AM; Al Sabaan FS; Haddad FH; Iraqi H; Elebrashy I; Assaad SN; Bayat Z; Osar Siva Z; Hassanein M
J Diabetes; 2022 May; 14(5):315-333. PubMed ID: 35434900
[TBL] [Abstract][Full Text] [Related]
2. Global survey investigating causes of treatment inertia in type 2 diabetes cardiorenal risk management.
Kanumilli N; Brunton S; Cos X; Deed G; Kushner P; Lin P; Nolte J
J Diabetes Complications; 2021 Mar; 35(3):107813. PubMed ID: 33419634
[TBL] [Abstract][Full Text] [Related]
3. Bridging the Gap for Patients with Diabetes and Cardiovascular Disease Through Cardiometabolic Collaboration.
Chang LS; Vaduganathan M; Plutzky J; Aroda VR
Curr Diab Rep; 2019 Dec; 19(12):157. PubMed ID: 31802265
[TBL] [Abstract][Full Text] [Related]
4. Glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for cardiovascular and renal protection: A treatment approach far beyond their glucose-lowering effect.
Gómez-Huelgas R; Sanz-Cánovas J; Cobos-Palacios L; López-Sampalo A; Pérez-Belmonte LM
Eur J Intern Med; 2022 Feb; 96():26-33. PubMed ID: 34799233
[TBL] [Abstract][Full Text] [Related]
5. Type 2 diabetes and pre-diabetes mellitus: a systematic review and meta-analysis of prevalence studies in women of childbearing age in the Middle East and North Africa, 2000-2018.
Al-Rifai RH; Majeed M; Qambar MA; Ibrahim A; AlYammahi KM; Aziz F
Syst Rev; 2019 Nov; 8(1):268. PubMed ID: 31703716
[TBL] [Abstract][Full Text] [Related]
6. Contemporary National Patterns of Eligibility and Use of Novel Cardioprotective Antihyperglycemic Agents in Type 2 Diabetes Mellitus.
Nargesi AA; Jeyashanmugaraja GP; Desai N; Lipska K; Krumholz H; Khera R
J Am Heart Assoc; 2021 Jul; 10(13):e021084. PubMed ID: 33998258
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 in People with Diabetes: Epidemiological Perspectives and Public Health Actions in the Middle East and North Africa (MENA) Region.
Al Dawish MA; Robert AA
Curr Diabetes Rev; 2021; 17(5):e211020187087. PubMed ID: 33087031
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of type 2 diabetes, prediabetes, and gestational diabetes mellitus in women of childbearing age in Middle East and North Africa, 2000-2017: protocol for two systematic reviews and meta-analyses.
Al-Rifai RH; Aziz F
Syst Rev; 2018 Jul; 7(1):96. PubMed ID: 30021654
[TBL] [Abstract][Full Text] [Related]
9. Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials.
Palmer SC; Tendal B; Mustafa RA; Vandvik PO; Li S; Hao Q; Tunnicliffe D; Ruospo M; Natale P; Saglimbene V; Nicolucci A; Johnson DW; Tonelli M; Rossi MC; Badve SV; Cho Y; Nadeau-Fredette AC; Burke M; Faruque LI; Lloyd A; Ahmad N; Liu Y; Tiv S; Millard T; Gagliardi L; Kolanu N; Barmanray RD; McMorrow R; Raygoza Cortez AK; White H; Chen X; Zhou X; Liu J; Rodríguez AF; González-Colmenero AD; Wang Y; Li L; Sutanto S; Solis RC; Díaz González-Colmenero F; Rodriguez-Gutierrez R; Walsh M; Guyatt G; Strippoli GFM
BMJ; 2021 Jan; 372():m4573. PubMed ID: 33441402
[TBL] [Abstract][Full Text] [Related]
10. Overcoming barriers to implementing new guideline-directed therapies for chronic kidney disease.
Nee R; Yuan CM; Narva AS; Yan G; Norris KC
Nephrol Dial Transplant; 2023 Feb; 38(3):532-541. PubMed ID: 36264305
[TBL] [Abstract][Full Text] [Related]
11. Patterns and trends in insulin initiation and intensification among patients with Type 2 diabetes mellitus in the Middle East and North Africa region.
Jabbar A; Abdallah K; Hassoun A; Malek R; Senyucel C; Spaepen E; Treuer T; Bhattacharya I
Diabetes Res Clin Pract; 2019 Mar; 149():18-26. PubMed ID: 30653994
[TBL] [Abstract][Full Text] [Related]
12. Cardiorenal Protection in Diabetic Kidney Disease.
Lee JF; Berzan E; Sridhar VS; Odutayo A; Cherney DZI
Endocrinol Metab (Seoul); 2021 Apr; 36(2):256-269. PubMed ID: 33873265
[TBL] [Abstract][Full Text] [Related]
13. SGLT2 Inhibition in Type 1 Diabetes with Diabetic Kidney Disease: Potential Cardiorenal Benefits Can Outweigh Preventable Risk of Diabetic Ketoacidosis.
Liu H; Sridhar VS; Perkins BA; Rosenstock J; Cherney DZI
Curr Diab Rep; 2022 Jul; 22(7):317-332. PubMed ID: 35633439
[TBL] [Abstract][Full Text] [Related]
14. Diabetes in the Middle-East and North Africa: an update.
Majeed A; El-Sayed AA; Khoja T; Alshamsan R; Millett C; Rawaf S
Diabetes Res Clin Pract; 2014 Feb; 103(2):218-22. PubMed ID: 24300017
[TBL] [Abstract][Full Text] [Related]
15. Strategic Recommendations to Bridge the Gaps in Awareness, Diagnosis and Prevention of Heart Failure in the Middle East Region and Africa.
Bennis A; Ogola EN; Klug E; Skouri HN; Al Saffar HB; Ragy H; AlGhalayini KW; Alhumood KA; Abdelhamid M; Yilmaz MB; Tabbalat R; Çavuşoğlu Y
J Saudi Heart Assoc; 2022; 34(1):53-65. PubMed ID: 35586274
[TBL] [Abstract][Full Text] [Related]
16. An emerging new concept for the management of type 2 diabetes with a paradigm shift from the glucose-centric to beta cell-centric concept of diabetes - an Asian perspective.
Saisho Y
Expert Opin Pharmacother; 2020 Sep; 21(13):1565-1578. PubMed ID: 32521177
[TBL] [Abstract][Full Text] [Related]
17. New Antidiabetes Medications and Their Cardiovascular and Renal Benefits.
Ferro EG; Elshazly MB; Bhatt DL
Cardiol Clin; 2021 Aug; 39(3):335-351. PubMed ID: 34247748
[TBL] [Abstract][Full Text] [Related]
18. Diabetes in the Middle East and North Africa.
Zabetian A; Kelli HM; Echouffo-Tcheugui JB; Narayan KM; Ali MK
Diabetes Res Clin Pract; 2013 Aug; 101(2):106-22. PubMed ID: 23642969
[TBL] [Abstract][Full Text] [Related]
19. Rationale for the Early Use of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with Type 2 Diabetes.
Handelsman Y
Adv Ther; 2019 Oct; 36(10):2567-2586. PubMed ID: 31444707
[TBL] [Abstract][Full Text] [Related]
20. Sodium Glucose Cotransporter-2 Inhibition and Cardiorenal Protection: JACC Review Topic of the Week.
Cherney DZ; Odutayo A; Aronson R; Ezekowitz J; Parker JD
J Am Coll Cardiol; 2019 Nov; 74(20):2511-2524. PubMed ID: 31727290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
